Toggle light / dark theme

I’m excited to share my new opinion article for Newsweek. It advocates for transforming America from a military-industrial complex into a science-industrial complex! Give it a read!


America spends 45 percent of its discretionary federal spending on defense and wars, while around us, the world burns in ways that have nothing to do with fighting or the military. Global warming has escalated into an enormous crisis. A fifth of everyone we know will die from heart disease. And an opioid crisis is reducing the average lifespans of Americans for the first time in decades. There’s plenty of tragedy, fear, and hardship all around us, but it has nothing to do with the need to make more bombs. It does, however, have to do with science.

It seems obvious America should do something different than spend so much of its tax dollars on defense. We should consider halving that money, and directing it to science, transforming America from a military-industrial complex into a science-industrial complex. Despite science and technological progress being broadly responsible for raising the standard of living around the world over the last 50 years, America spends only 3 percent of its GDP ($205 billion) on science and medical research across the federal government. Notably, this is dramatically less than the $877 billion the U.S. will spend on defense this year.

The famous designation of the term military-industrial complex comes from former President Dwight D. Eisenhower in his farewell address, where he warned America and its economy could descend into being a conflict-driven nation. Over 60 years after his speech, we have become just that. A Brown University study found that since 2001, the U.S. has spent $5.9 trillion on wars in the Middle East and Asia. For contrast, the 2023 budget for the National Institutes of Health (NIH) is a paltry $49 billion.

Canada: The European Society of Cardiology (ESC) has taken a significant stride in the field of heart failure management with a focused update to their heart failure guidelines. This update incorporates crucial data from nearly a dozen new clinical trials that have been published since 2021. The trials include notable studies such as EMPEROR-Preserved, DELIVER, STRONG-HF, IRONMAN, and more. The updated guidelines, which were unveiled on the opening day of the ESC Congress 2023, offer novel recommendations related to the use of SGLT2 inhibitors in patients with heart failure and updates on comorbidity management.

New Recommendations:

• Encryption and segmentation: These operate on the assumption some fraction of the network is already compromised. Restricting the reach and utility of any captured data and accessible networks will mitigate the damage even on breached systems.

• SBOM documentation: Regulatory compliance can be driven by industry organizations and the government, but it will take time to establish standards. SBOM documentation is an essential foundation for best practices.

If “democracy dies in darkness,” and that includes lies of omission in reporting, then cybersecurity suffers the same fate with backdoors. The corollary is “don’t roll your own crypto” even if well-intentioned. The arguments for weakening encryption to make law enforcement easier falls demonstrably flat, with TETRA just the latest example. Secrets rarely stay that way forever, and sensitive data is more remotely accessible than at any time in history. Privacy and global security affect us all, and the existence of these single points of failure in our cybersecurity efforts are unsustainable and will have unforeseeable consequences. We need to innovate and evolve the internet away from this model to have durable security assurances.

Tech executives, researchers and government officials are gathering in Seattle this week to figure out ways to add a new dimension to America’s chip industry — figuratively and literally.

“We’re going to talk about a once-in-a-lifetime opportunity to reinvent domestic microelectronics manufacturing,” Mark Rosker, director of the Defense Advanced Research Projects Agency’s Microsystems Technology Office, said today at the opening session of the ERI 2.0 Summit at the Hyatt Regency Seattle.

More than 1,300 attendees signed up for the DARPA event, which follows up on a series of Electronics Resurgence Initiative Summits that were conducted before the COVID-19 pandemic.

Dr. Joni L. Rutter, Ph.D., (https://ncats.nih.gov/director/bio) is the Director of the National Center for Advancing Translational Sciences (NCATS — https://ncats.nih.gov/) at the U.S. National Institutes of Health (NIH) where she oversees the planning and execution of the Center’s complex, multifaceted programs that aim to overcome scientific and operational barriers impeding the development and delivery of new treatments and other health solutions. Under her direction, NCATS supports innovative tools and strategies to make each step in the translational process more effective and efficient, thus speeding research across a range of diseases, with a particular focus on rare diseases.

By advancing the science of translation, NCATS helps turn promising research discoveries into real-world applications that improve people’s health. The NCATS Strategic Plan can be found at — https://ncats.nih.gov/strategicplan.

In her previous role as the NCATS deputy director, Dr. Rutter collaborated with colleagues from government, academia, industry and nonprofit patient organizations to establish robust interactions with NCATS programs.

Prior to joining NCATS, Dr. Rutter served as the director of scientific programs within the All of Us Research Program, where she led the scientific programmatic development and implementation efforts to build a national research cohort of at least 1 million U.S. participants to advance precision medicine. During her time at NIH, she also has led the Division of Neuroscience and Behavior at the National Institute on Drug Abuse (NIDA). In this role, she developed and coordinated research on basic and clinical neuroscience, brain and behavioral development, genetics, epigenetics, computational neuroscience, bioinformatics, and drug discovery. Dr. Rutter also coordinated the NIDA Genetics Consortium and biospecimen repository.

Led by the Aerospace Technology Institute (ATI) and backed by the UK government, FlyZero has concluded that green liquid hydrogen is the optimum fuel for zero-carbon emission flight and could power a midsize aircraft with 280 passengers from London to San Francisco directly, or from London to Auckland with just one stop.


FlyZero, the UK study into zero-carbon emission commercial air travel, has published its vision for a new generation of aircraft powered by liquid hydrogen, today Thursday 17th March.

The report Our Vision for Zero-Carbon Emission Air Travel marks the conclusion of a 12-month study which set out to consider the feasibility of zero-carbon emission aircraft. The project concludes aviation can achieve net zero 2050 through the development of both sustainable aviation fuel (SAF) and green liquid hydrogen technologies.

To secure market share on new hydrogen-powered aircraft, UK companies must be ready to demonstrate technologies by 2025. This timescale is key for new zero-carbon emission aircraft to enter service by 2035 and to achieve the net zero 2050 target.

NASA’s Parker Solar Probe marks five successful years in space, achieving milestones like touching the Sun and collecting more than double the expected data. The mission’s continuing journey promises to deepen our understanding of space weather and the Sun’s effects on Earth. Credit: NASA GSFC/CIL/Brian Monroe.

NASA

Established in 1958, the National Aeronautics and Space Administration (NASA) is an independent agency of the United States Federal Government that succeeded the National Advisory Committee for Aeronautics (NACA). It is responsible for the civilian space program, as well as aeronautics and aerospace research. Its vision is “To discover and expand knowledge for the benefit of humanity.” Its core values are “safety, integrity, teamwork, excellence, and inclusion.” NASA conducts research, develops technology and launches missions to explore and study Earth, the solar system, and the universe beyond. It also works to advance the state of knowledge in a wide range of scientific fields, including Earth and space science, planetary science, astrophysics, and heliophysics, and it collaborates with private companies and international partners to achieve its goals.

After the U.S. government imposed crippling sanctions against select Chinese high-tech and supercomputer companies through 2019 and 2020, firms like Huawei had to halt chip development; it is impossible to build competitive processors without access to leading-edge nodes. But Jiangnan Computing Lab, which develops Sunway processors, and National Supercomputing Center in Wuxi kept building new supercomputers and recently even submitted results of their latest machine for the Association for Computing Machinery’s Gordon Bell prize.

The new Sunway supercomputer built by the National Supercomputing Center in Wuxi (an entity blacklisted in the U.S.) employs around feature approximately 19.2 million cores across 49,230 nodes, reports Supercomputing.org. To put the number into context, Frontier, the world’s highest-performing supercomputer, uses 9,472 nodes and consumes 21 MW of power. Meanwhile, the National Supercomputing Center in Wuxi does not disclose power consumption of its latest system.